arrow
Back
P

Paul Harmatz

University of North Carolina School of Medicine

65H-index
532Paper Count
1.5WCitation Count
Published Papers 234
Publication Date
Intrathecal idursulfase-IT in children younger than 3 years with neuronopathic mucopolysaccharidosis II in a single-arm, open-label, phase 2/3 substudy and extension
err2026-02-22
err0
errOAAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Gutierrez-solana, Luis Gonzalez; Ruiz-garcia, Matilde; Jones, Simon A.; Guffon, Nathalie; Inbar-feigenberg, Michal; Bratkovic, Drago; Rust, Stewart; Hale, Michael; Wu, Yuna; Yee, Karen S.; Whiteman, David A. H.; Alexanderian, David
errShare
errSave
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
err2026-01-01
err4
PREAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Rajan, Deepa S.; Jones, Simon A.; van den Hout, Johanna M. P.; Mitchell, John J.; Bhalla, Akhil; Engmann, Natalie J.; Zubizarreta, Imanol; Dong, Wei; Model, Fabian; Watts, Ryan J.; Troyer, Matthew D.; Chin, Peter S.; Ho, Carole
errShare
errSave
Clinical characteristics and real-world outcomes in patients with mucopolysaccharidosis II over 18 years: final report of the hunter outcome survey
err2025-11-02
err0
PREAI
errJoseph Muenzer; Jaco Botha; Hernan Amartino; Roberto Giugliani; Paul Harmatz; Christoph Kampmann; Bianca Link; Shuan-Pei Lin; David Molter; Julian Raiman; Maurizio Scarpa; Anna Tylki-Szymańska; Siddharth Jain; David A.H. Whiteman; Barbara K. Burton
errShare
errSave
Liver iron susceptometry is different in patients with transfusion dependent thalassemia and sickle cell disease compared with hemochromatosis
err2025-11-01
err0
errOAAI
errFischer, Roland; Weyhmiller, Marcela G.; Fung, Ellen B.; Pakbaz, Zahra; Paulson, Doug N.; Vichinsky, Elliott P.; Nielsen, Peter; Harmatz, Paul R.
errShare
errSave
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial
err2025-07-07
err0
PREAI
errEugen Mengel; Rosalia M. Da Riol; Mireia Del Toro; Federica Deodato; Matthias Gautschi; Stephanie Grunewald; Sabine Weller Grønborg; Paul Harmatz; Julia B. Hennermann; Bénédicte Héron; Esther M. Maier; Saikat Santra; Reena Sharma; Anna Tylki-Szymanska; Malene Cording; Louise Himmelstrup; Sven Guenther; Christine í Dali
errShare
errSave
Long-term enzyme replacement therapy: Findings from the mucopolysaccharidosis VI clinical surveillance program after 15 years follow-up
err2025-07-01
err0
errOAAI
errBurton, Barbara K.; Harmatz, Paul R.; Horvathova, Veronika; Lail, Alice; Lampe, Christina; Parini, Rossella; Sharma, Reena; Teles, Elisa Lea
errShare
errSave
Safety of anesthesia in mucopolysaccharidoses - A comparative retrospective cohort study on more than 600 cases
err2025-06-01
err0
PREAI
errMoser, Simon; Harmatz, Paul; Rhoads, William; Rowe, Richard; Lagler, Florian B.
errShare
errSave
Gangliosidoses: Understanding disease evolution in GM1 and GM2
err2025-02-01
err0
PREAI
errGiugliani, Roberto; Harmatz, Paul; Heron, Benedicte; Hahn, Andreas; Patterson, Marc; Bourchany, Aurelie; Valle, Daniel A. D.; Barone, Rita Maria Elisa; Chabrol, Brigitte; Ardissone, Anna; Batzios, Spyros; Scarpa, Maurizio; Schneider, Susanne A.; Carp, Nicoleta; Freitag, Christian; Gill, Aidan; de Frutos, Laura Lopez
errShare
errSave
Campsiite® phase I/II/III: an interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)
err2025-02-01
err0
PREAI
errHarmatz, Paul; Ficicioglu, Can; Giugliani, Roberto; Rajan, Deepa; Day-Salvatore, Debra-Lynn; Hagood, Joseph; Gilmor, Michelle; Cho, Yoonjin; Mulatya, Caroline; Phillips, Dawn; Boulos, Nidal; Pisani, Laura; Falabella, Paulo
errShare
errSave
Application of a natural history study on an investigational drug clinical development
err2025-02-01
err0
PREAI
errGiugliani, Roberto; Valle, Daniel A. D.; Heron, Benedicte; Harmatz, Paul; Hahn, Andreas; Horovitz, Dafne D. G.; Patterson, Marc; Bourchany, Aurelie; Barone, Rita Maria Elisa; Chabrol, Brigitte; Ardissone, Anna; Batzios, Spyros; Scarpa, Maurizio; Schneider, Susanne A.; Carp, Nicoleta; Freitag, Christian; Gill, Aidan; de Frutos, Laura Lopez
errShare
errSave
Anesthesia in mucopolysaccharidoses - Retrospective analysis and insights of a large cohort
err2025-02-01
err0
PREAI
errMoser, Simon; Harmatz, Paul; Rhoads, William; Rowe, Richard; Lagler, Florian
errShare
errSave
Baseline data from the proof of concept study to evaluate the safety and early efficacy of vosoritide for the treatment of growth deficits in MPS IVA and VI
err2025-02-01
err0
PREAI
errFung, Ellen B.; Gibson, Eden; Lynch, Leslie; Madden, Jacqueline; Kammen, Bamidele; Chang, Irene; Harmatz, Paul
errShare
errSave
A phase 1/2 study of LY3884961 (PR001) an AAV9-based gene therapy for Gaucher disease type 2-A clinical update from the PROVIDE trial
err2025-02-01
err0
PREAI
errNeuhaus, Sarah; Tamburri, Paul; Whitley, Chester B.; Jones, Simon A.; Donald, Aimee; Harmatz, Paul; Blair, David R.; Chang, Irene; Gallagher, Renata C.; Rajan, Deepa S.; Goker-Alpan, Ozlem; Beckerman, Yael; Lopez, Victor A.; Hatch, Daniel; Shaughnessy, Lee
errShare
errSave
Building safe systems for patients with mucopolysaccharidoses (MPS) - Results of an expert survey on patient safety
err2025-02-01
err0
PREAI
errLagler, Florian B.; Stepien, Karolina M.; Akyol, Umut; Lampe, Christina; Bruce, Iain A.; Walker, Robert; De Souza, Carolina Fischinger Moura; Mitchell, John J.; Harmatz, Paul; Giugliani, Roberto
errShare
errSave
Interim analysis of the efficacy and safety of weekly intravenous tividenofusp alfa in mucopolysaccharidosis type II (MPS II): A phase 1/2 study
err2025-02-01
err0
PREAI
errMuenzer, Joseph; Burton, Barbara K.; Harmatz, Paul; Rajan, Deepa; Jones, Simon; van den Hout, Hannerieke J. M.; Mitchell, John J.; Troyer, Matt; Engmann, Natalie; Caprihan, Rupa; Bhalla, Akhil; Zubizarreta, Imanol; Weichert, Arlette; Chin, Peter; Ho, Carole
errShare
errSave
Interim results from a first in human phase 1 clinical trial of in utero enzyme replacement therapy for lysosomal disorders
err2025-02-01
err0
PREAI
errMackenzie, Tippi C.; Lianoglou, Billie; Canepa, Emma; Herzeg, Akos; Borgas, Beltran; Cohen, Jennifer L.; Bali, Deeksha; Young, Sarah; Gonzalez-Vele, Juan; Munar, Dane; Gelb, Michael H.; Herbs, Zackary (Ari) M.; Chakraborty, Pranesh; Kishnani, Priya; Harmatz, Paul
errShare
errSave
Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases
err2025-01-31
err0
PREAI
errBorges, B; Canepa, E; Chang, IJ; Herzeg, A; Lianoglou, B; Kishnani, PS; Harmatz, P; Mackenzie, TC; Cohen, JL
errShare
errSave
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life
err2024-12-01
err0
errOAAI
errSavarirayan, Ravi; Irving, Melita; Wilcox, William R.; Bacino, Carlos A.; Hoover-Fong, Julie E.; Harmatz, Paul; Polgreen, Lynda E.; Mohnike, Klaus; Prada, Carlos E.; Kubota, Takuo; Arundel, Paul; Leiva-Gea, Antonio; Rowell, Richard; Low, Andrea; Sabir, Ian; Huntsman-Labed, Alice; Day, Jonathan
errShare
errSave
CAMPSIITET Phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)
err2024-04-01
err0
PREAI
errPisani, Laura; Ficicioglu, Can; Harmatz, Paul; Giugliani, Roberto; Rajan, Deepa; Hagood, Joseph; Fiscella, Michele; Yang, Lin; Gilmor, Michelle; Cho, Yoonjin; Mulatya, Caroline; Phillips, Dawn; Boulos, Nidal; Falabella, Paulo
errShare
errSave
α- L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial
err2024-03-01
err1
errOAAI
errHarmatz, Paul; Giugliani, Roberto; Martins, Ana Maria; Hamazaki, Takashi; Kubo, Toru; Kira, Ryutaro; Minami, Kohtaro; Ikeda, Toshiaki; Moriuchi, Hiroaki; Kawashima, Satoshi; Takasao, Naoko; So, Sairei; Sonoda, Hiroyuki; Hirato, Tohru; Tanizawa, Kazunori; Schmidt, Mathias; Sato, Yuji
errShare
errSave